ArticleThe Gerontologist2026
Hearing screening for healthy aging: the U.K. should take a targeted approach.
Article in The Gerontologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Targeted adult hearing loss screening in the UK: policy options for equitable implementation through health-service pathways.Frontiers in public health · 2026Article
- Dementia and hearing loss: from risk to mechanisms and management.Frontiers in dementia · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Hearing loss affects an estimated 18 million U.K. adults and is the third leading cause of years lived with disability worldwide. Hearing loss diminishes quality of life, activities of daily living, mental health, and negatively impacts the economy. When left unaddressed, hearing loss exacerbates health inequalities and is associated with an increased risk of developing dementia. Hearing loss and dementia frequently co-occur and have overlapping risk factors. People from disadvantaged backgrounds typically access hearing and memory services at a more progressed stage of their conditions. Early intervention is essential to mitigate negative effects and reduce disease burden. Universal adult hearing screening is not currently recommended by the U.K. National Screening Committee, despite evidence of cost-effectiveness and international recommendations. We argue that the U.K. should adopt targeted, risk-stratified screening that prioritizes those at greatest risk of dementia and people in deprived communities, where unmet need is highest. Such an approach is practical, equitable, and consistent with the Governments' prevention and personalized care agenda set out in the 10-year Health Plan for England. We outline the evidence, discuss implementation pathways and targeting strategies, and call on policymakers to commission a targeted, risk-stratified adult hearing screening pilot. A successful program would address unmet need, reduce inequalities, and further inform global debates on hearing screening strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.